Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Galapagos NV ADR
GXEACurrent price
25 EUR
-0.2 EUR (-0.79%)
Last closed
27.9 USD
Company
www.glpg.com
ISIN
US36315X1019
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
1 806 116 992 USD
Yield for 12 month
-27.49 %
1Y
3Y
5Y
10Y
15Y
GXEA
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Address: Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30.55 USDP/E ratio
–Dividend Yield
–Current Year
+255 497 114 USD
Last Year
+538 525 896 USD
Current Quarter
+82 996 808 USD
Last Quarter
+82 996 808 USD
Current Year
+255 471 535 USD
Last Year
+525 652 135 USD
Current Quarter
+65 350 407 USD
Last Quarter
+65 350 408 USD
Key Figures GXEA
1 year
3 years
5 years
10 years
EBITDA
-136 034 752 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-2.38 %
PEG Ratio
–
Return On Equity TTM
-2.21 %
Wall Street Target Price
30.55 USD
Revenue TTM
260 094 000 USD
Book Value
43.41 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-50.1 %
Dividend Yield
–
Gross Profit TTM
4 818 000 USD
Earnings per share
-0.99 USD
Diluted Eps TTM
-0.99 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
74.8 %
Profit Margin
79.33 %
Dividend Analytics GXEA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GXEA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GXEA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
166.6667
Enterprise Value Revenue
1.1836
Price Sales TTM
6.9441
Enterprise Value EBITDA
-31.4982
Price Book MRQ
0.5805
Financials GXEA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GXEA
For 52 weeks
24.16 USD
42.46 USD
50 Day MA
29 USD
Shares Short Prior Month
1 513 170
200 Day MA
29.8 USD
Short Ratio
14.21
Shares Short
1 516 067
Short Percent
3.08 %
BeatStart